BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang S, Lu Y, Jiang HY, Cheng ZM, Wei ZJ, Wei YH, Liu T, Xia BJ, Zhao XY, Huang Y, Zou X, Liu R, Zhou S. CircC16orf62 promotes hepatocellular carcinoma progression through the miR-138-5p/PTK2/AKT axis. Cell Death Dis 2021;12:597. [PMID: 34108451 DOI: 10.1038/s41419-021-03866-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Li TT, Mou J, Pan YJ, Huo FC, Du WQ, Liang J, Wang Y, Zhang LS, Pei DS. MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway. J Biomed Sci 2021;28:56. [PMID: 34340705 DOI: 10.1186/s12929-021-00752-4] [Reference Citation Analysis]
2 Weng X, Lu XJ. Circular RNA and human diseases: Basic research and translational implications. Cell Signal 2021;86:110100. [PMID: 34329729 DOI: 10.1016/j.cellsig.2021.110100] [Reference Citation Analysis]
3 Mao G, Shan C, Li W, Liang B, Ma L, Zhang S. High Expression of RRM1 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma. IJGM 2022;Volume 15:2607-20. [DOI: 10.2147/ijgm.s353362] [Reference Citation Analysis]
4 Khashkhashi Moghadam S, Bakhshinejad B, Khalafizadeh A, Mahmud Hussen B, Babashah S. Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma. J Cell Mol Med 2021. [PMID: 34907642 DOI: 10.1111/jcmm.17126] [Reference Citation Analysis]
5 Li D, Zhang J, Yang J, Wang J, Zhang R, Li J, Zhang R. CircMTO1 suppresses hepatocellular carcinoma progression via the miR-541-5p/ZIC1 axis by regulating Wnt/β-catenin signaling pathway and epithelial-to-mesenchymal transition. Cell Death Dis 2021;13:12. [PMID: 34930906 DOI: 10.1038/s41419-021-04464-3] [Reference Citation Analysis]